RaDVaC Data Explorer
Antiviral database
Virus Taxonomy
← Back to Dashboard
Lamivudine
RT inhibitor and zalcitabine analog
2D Structure
Loading structure...
3D Structure
Loading 3D structure...
Chemical Identifiers
SMILES:
C1C(OC(S1)CO)N2C=CC(=NC2=O)N
InChI Key:
JTEGQNOMFQHVDC-NKWVEPMBSA-N
ClinicalTrials.gov
PubMed
Clinical Development by Virus
4
Human immunodeficiency virus (HIV)
HIV
Target: NRTIs
FDA approved
Preclinical
Phase 2
positive
Phase 3
positive
Approved
FDA
Japan
China
Russia
Approval ref: AntiviralDb
Approval ref (kegg.jp)
Approval ref (pmda.go.jp)
Hepatitis B virus
HBV
Target: Viral RT
FDA approved
Preclinical
Phase 2
positive
Phase 3
positive
Approved
FDA
Japan
China
Russia
Approval ref (kegg.jp)
Approval ref (pmda.go.jp)
PubChem CID:60825
DB00709
Human immunodeficiency virus 1
HIV-1
Target: Viral RT
FDA approved
Preclinical
Phase 2
positive
Phase 3
positive
Approved
FDA
Japan
China
Russia
Approval ref (kegg.jp)
Approval ref (pmda.go.jp)
PubChem CID:60825
DB00709
Human immunodeficiency virus 2
HIV-2
Target: Viral RT
FDA approved
Preclinical
Phase 2
positive
Phase 3
positive
Approved
FDA
Japan
China
Russia
Approval ref (kegg.jp)
Approval ref (pmda.go.jp)
PubChem CID:60825
DB00709